Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing 51 - 75 of 267
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Oct 31, 2022

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

    Recruiting
    • Acute Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 26, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Ublituximab, Ibrutinib)

    Completed
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • Huntsville, Alabama
    • +17 more
    Oct 21, 2022

    Mantle Cell Lymphoma Trial in Duarte, Ann Arbor, Columbus (Venetoclax, Lenalidomide, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Duarte, California
    • +2 more
    Oct 18, 2022

    Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

    Recruiting
    • Mantle Cell Lymphoma
    • Ketogenic Dieting
    • Ketogenic Diet
    • New York, New York
      Weill Cornell Medicine
    Oct 17, 2022

    Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

    Completed
    • Lymphoma
    • +3 more
    • Basking Ridge, New Jersey
    • +5 more
    Oct 7, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Miami (Thalidomide)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Non-Hodgkin's Lymphoma
    • Miami, Florida
      University of Miami
    Sep 14, 2022

    Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 13, 2022

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • Mantle Cell Lymphoma
    • Monterey, California
    • +4 more
    Aug 29, 2022

    Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Spokane, Washington
    • +1 more
    Aug 12, 2022

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in United States (Abexinostat, Ibrutinib)

    Active, not recruiting
    • Diffuse Large B-cell Lymphoma
    • Mantle Cell Lymphoma
    • Basking Ridge, New Jersey
    • +6 more
    Aug 11, 2022

    Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

    Not yet recruiting
    • Lymphoma
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 10, 2022

    Mantle Cell Lymphoma, Refractory Lymphoma Trial in Boston (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • Refractory Lymphoma
    • Boston, Massachusetts
    • +1 more
    Aug 8, 2022

    Recurrent Refractory Mantle Cell Lymphoma

    Recruiting
    • Mantle Cell Lymphoma
      • Beijing, Beijing, China
        Peking University Third Hospital
      Aug 1, 2022

      Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

      Withdrawn
      • Asymptomatic COVID-19 Infection Laboratory-Confirmed
      • +8 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 2, 2022

      Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

      Recruiting
      • Relapsed/Refractory B-cell Lymphomas
      • +11 more
      • CLBR001 and SWI019
      • Duarte, California
      • +7 more
      Jul 26, 2022

      Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

      Not yet recruiting
      • Mantle Cell Lymphoma
      • +2 more
      • (no location specified)
      Jul 25, 2022

      DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

      Terminated
      • Diffuse Large B-Cell Lymphoma
      • +4 more
      • Ublituximab
      • +2 more
      • Birmingham, Alabama
      • +167 more
      Jul 20, 2022

      B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

      Recruiting
      • B-cell Malignancy, Low-grade
      • +4 more
      • Beijing, Beijing, China
      • +8 more
      Jul 20, 2022